COMMUNIQUÉS West-GlobeNewswire

Sharecare launches Sharecare Awards in association with The National Academy of Television Arts & Sciences, New York Chapter
09/10/2018
First-of-its-kind awards to honor excellence in health and wellness productions and programming; call for entries open through December 15 ATLANTA and NEW YORK, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Sharecare, the digital [...]
Portola Pharmaceuticals Supports 2018 World Thrombosis Day Campaign to Raise Awareness of Blood Clots as an Urgent and Growing Health Crisis
09/10/2018
Highlights Proactive Risk Assessment in Hospitals as Opportunity to Optimize Patient Outcomes SOUTH SAN FRANCISCO, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced [...]
Axovant Announces Data to be Presented at the Annual Congress of the European Society of Gene and Cell Therapy
09/10/2018
BASEL, Switzerland, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ:AXON), a gene therapy company developing innovative treatments for debilitating neurologic and neuromuscular diseases, today announced [...]
Daina Schmidt Joins Obalon Therapeutics As Vice President, Marketing
09/10/2018
SAN DIEGO, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric [...]
Adventist Health Expands Program for Diabetic Retinopathy Screening
09/10/2018
Western U.S. Health Nonprofit Seizes Opportunity to Treat the Whole Patient by Integrating Advanced Screening Technology in 37 Hospitals and Clinics ROSEVILLE, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Adventist Health [...]
Juneau Biosciences Presents New Genetic Discoveries in Endometriosis at ASRM Scientific Congress & Expo
09/10/2018
Presentation at premier infertility conference by Predictive Technology Group subsidiary awarded “Best in Clinical/Population Science Prize Paper” SALT LAKE CITY, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Predictive Technology [...]
APC Comments on Favorable Results in Initial Animal Studies
09/10/2018
VANCOUVER, British Columbia, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) , is pleased to report favorable results in initial animal [...]
Avalon GloboCare Teams Up with Weill Cornell Medicine to Co-develop Standardization of cGMP-Grade Exosome Isolation and Application of Tissue-Specific Exosomes
09/10/2018
FREEHOLD, N.J., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB: AVCO) , a leading global developer of cell-based technologies and therapeutics, announced today that Weill Cornell Medicine has selected [...]
Rafael Pharmaceuticals to Present at BIO Investor Forum 2018
09/10/2018
Newark, NJ, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced that Sanjeev Luther, its President and Chief Executive [...]
CV Sciences, Inc.’s PlusCBD Oil™ featured on Oct. 3rd Episode of ‘The Dr. Oz Show’
09/10/2018
PlusCBD Oil™ Capsules featured as one of the industry-leading in efficacy and strength; Dr. Oz segment cites sales of CBD products expected to increase 700% over the next year LAS VEGAS, Oct. 09, 2018 (GLOBE NEWSWIRE [...]
Genocea Announces Upcoming Presentations at SITC 2018
09/10/2018
Posters showcase ability of ATLAS™ platform to identify neoantigens for inclusion in and exclusion from personalized immunotherapies CAMBRIDGE, Mass., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ [...]
Hemostemix Announces Three Additional Sites Enrolled in Phase II Clinical Trial
09/10/2018
CALGARY, Alberta, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM) is pleased to announce that it has received all approvals from three new medical centers to be [...]
Arbutus Provides Update on HBV Development Programs and Announces Appointment of Dr. Gaston Picchio as Chief Development Officer
09/10/2018
Dr. Mark Murray, Arbutus President & Chief Executive Officer, to participate in a fireside chat at Chardan’s Genetic Medicines Conference at 2:45 pm ET today WARMINSTER, Pa., Oct. 09, 2018 (GLOBE NEWSWIRE) -- [...]
New Data from Adult ADHD Clinical Trial to be Presented at the 65th Annual AACAP Meeting
09/10/2018
Prof. Stephen Faraone, Ph.D. to present on October 25 in Seattle, Washington COLUMBIA, Md., Oct. 09, 2018 (GLOBE NEWSWIRE) -- VAYA™ Pharma, Inc. (VAYA™), a division of Frutarom, Inc., and leader in developing specialty [...]
Ritter Pharmaceuticals Presents Additional Phase 2b Data Showing Adaptation of the Gut Microbiome in Lactose Intolerance Patients at American College of Gastroenterology Scientific Meeting
09/10/2018
LOS ANGELES, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to [...]
CRUZANI Begins Product Development with Cannabis Derivatives for Edible and Infusion Markets
09/10/2018
ATLANTA, Oct. 09, 2018 (GLOBE NEWSWIRE) -- CRUZANI, Inc. (OTC Markets: CZNI) is a global business development company focused on creating and acquiring franchise concepts, along with peripheral food-related businesses [...]
Precision Therapeutics’ Skyline Medical Division Signs International Distribution Agreement with India-based Prenit World
09/10/2018
MINNEAPOLIS, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) is pleased to announce that its Skyline Medical division, producer of the FDA-approved and CE- [...]
Bellerophon Provides Update on INOpulse® Phase 2b Clinical Program for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
09/10/2018
Enrollment of the Planned 40 Subjects Completed, with Top-line Data Expected in January 2019 WARREN, N.J., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company [...]
Progenics Announces Publication of Pivotal Trial of AZEDRA® (iobenguane I 131) in The Journal of Nuclear Medicine
09/10/2018
NEW YORK, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, today [...]

Pages